Search Results - "Pinkerton, JoAnn"

Hormone Therapy for Postmenopausal Women by Pinkerton, JoAnn V

“…Hormone therapy is highly effective for the management of vasomotor symptoms in postmenopausal women; vaginal estrogen is used for genitourinary symptoms only…”
Get full text

Female Sexual Arousal Disorder: Sildenafil Cream as Potential Treatment in Development by Pinkerton, JoAnn V

Get full text

Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice Guideline by Stuenkel, Cynthia A, Davis, Susan R, Gompel, Anne, Lumsden, Mary Ann, Murad, M. Hassan, Pinkerton, JoAnn V, Santen, Richard J

“…Objective: The objective of this document is to generate a practice guideline for the management and treatment of symptoms of the menopause. Participants: The…”
Get full text

Use of SERMs for treatment in postmenopausal women by Pinkerton, JoAnn V., Thomas, Semara

“…•FDA approved selective estrogen receptor modulators (SERMs) prevent and treat breast cancer, osteoporosis and dyspareunia.•SERMs have varying agonist and…”
Get full text

Concerns About Compounded Bioidentical Menopausal Hormone Therapy by Pinkerton, JoAnn V.

“…Following the release of the Women's Health Initiative data, women began to use compounded bioidentical hormone therapy (cBHT) in the misguided belief of…”
Get full text

Selective Estrogen Receptor Modulators in Gynecology Practice by Pinkerton, JoAnn V.

“…Selective estrogen receptor (ER) modulators have variable tissue specific estrogen agonist and antagonist activities. Tamoxifen is approved for treatment and…”
Get full text

Hormone Therapy for Postmenopausal Women. Reply by Pinkerton, JoAnn V

Get full text

Concerns about safety and efficacy of compounded bioidentical hormone therapy by Pinkerton, JoAnn V.

Get full text

Managing Menopausal Symptoms and Associated Clinical Issues in Breast Cancer Survivors by Santen, Richard J, Stuenkel, Cynthia A, Davis, Susan R, Pinkerton, JoAnn V, Gompel, Anne, Lumsden, Mary Ann

“…Review evidence to guide management of menopausal signs and symptoms in women after breast cancer and make recommendations accordingly. Randomized controlled…”
Get full text

Tissue-selective Estrogen Complex for Menopausal Hormone Therapy by PINKERTON, JOANN V

“…The first approved tissue-selective estrogen complex is a pairing of conjugated estrogen combined with the selective estrogen-receptor modulator, bazedoxifene…”
Get full text

Global Consensus Position Statement on the Use of Testosterone Therapy for Women by Davis, Susan R, Baber, Rodney, Panay, Nicholas, Bitzer, Johannes, Perez, Sonia Cerdas, Islam, Rakibul M, Kaunitz, Andrew M, Kingsberg, Sheryl A, Lambrinoudaki, Irene, Liu, James, Parish, Sharon J, Pinkerton, JoAnn, Rymer, Janice, Simon, James A, Vignozzi, Linda, Wierman, Margaret E

“…Abstract This Position Statement has been endorsed by the International Menopause Society, The Endocrine Society, The European Menopause and Andropause…”
Get full text

Reassuring data regarding the use of hormone therapy at menopause and risk of breast cancer by Pinkerton, JoAnn V., Wilson, Carolyn S., Kaunitz, Andrew M.

Get full text

Hormone Therapy: Key Points From NAMS 2017 Position Statement by PINKERTON, JOANN V

“…The goal of the 2017 North American Menopause Society Hormone Therapy (HT) Position Statement is to remove fear about HT and encourage individualized shared…”
Get full text

Changing the conversation about hormone therapy by Pinkerton, JoAnn V

Get full text

Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile by Lobo, Rogerio A., M.D, Pinkerton, JoAnn V., M.D, Gass, Margery L.S., M.D, Dorin, Maxine H., M.D, Ronkin, Sheila, M.D, Pickar, James H., M.D, Constantine, Ginger, M.D

“…Objective To evaluate the effects of a tissue-selective estrogen complex (TSEC) composed of bazedoxifene/conjugated estrogens (BZA/CE) on menopausal symptoms,…”
Get full text

Compounded bioidentical hormone therapy: identifying use trends and knowledge gaps among US women by Pinkerton, JoAnn V, Santoro, Nanette

“…OBJECTIVE:Two surveys (Harris and Rose surveys) were conducted to quantify the use of compounded hormone therapy (CHT; or bioidentical hormone therapy) among…”
Get full text

Neurokinin Receptor Antagonist, Fezolinetant, for Treatment of Menopausal Vasomotor Symptoms by Pinkerton, JoAnn V, Redick, Dana L, Homewood, Laura N, Kaunitz, Andrew M

“…Key Words: fezolinetant, vasomotor symptoms, neurokinin 3 receptor antagonist, KNDy, nonhormonal…”
Get full text

Effects of Bazedoxifene/Conjugated Estrogens on the Endometrium and Bone: A Randomized Trial by Pinkerton, JoAnn V, Harvey, Jennifer A, Lindsay, Robert, Pan, Kaijie, Chines, Arkadi A, Mirkin, Sebastian, Archer, David F

“…Objective: This phase 3 study evaluated the endometrial safety of bazedoxifene (BZA)/conjugated estrogens (CE) and bone mineral density (BMD) effects vs BZA…”
Get full text

The Women's Health Initiative trials of menopausal hormone therapy: lessons learned by Manson, JoAnn E., Bassuk, Shari S., Kaunitz, Andrew M., Pinkerton, JoAnn V.

“…OBJECTIVE:The Womenʼs Health Initiative (WHI) assessed oral conjugated equine estrogens (CEE) taken with or without medroxyprogesterone acetate (MPA) for…”
Get full text

Female Sexual Health: Barriers to Optimal Outcomes and a Roadmap for Improved Patient-Clinician Communications by Kingsberg, Sheryl A, Schaffir, Jonathan, Faught, Brooke M, Pinkerton, JoAnn V, Parish, Sharon J, Iglesia, Cheryl B, Gudeman, Jennifer, Krop, Julie, Simon, James A

“…Although sexual health can be considered a vital sign for overall health, several barriers prevent women from receiving proper medical counseling, support,…”
Get more information